Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 2003;11(1):1–9. doi: 10.1155/S1064744903000012

Compliance With Protocols for Prevention of Neonatal Group B Streptococcal Sepsis: Practicalities and Limitations

Gwendolyn L Gilbert 1,✉, Moira C Hewitt 2,3, Catherine M Turner 1, Stephen R Leeder 2
PMCID: PMC1852267  PMID: 12839627

Abstract

Objective: To compare two protocols for intrapartum antibiotic prophylaxis (IAP) against neonatal group B streptococcal (GBS) sepsis, with respect to staff compliance, in a prospective cohort study in the obstetric units of a community hospital (A) and a university teaching hospital (B).

Methods: Cohorts comprised about 500 women attending antenatal clinics at each hospital (total 1096). Women identified as GBS carriers at 26–32 weeks'gestation and those who had intrapartum clinical risk factors (CRF) were eligible for IAP. Compliance was defined as the proportion of women eligible for IAP who received it according to protocol–as determined by audit of case records–and compared between hospitals and according to indication.

Results: Overall, 39% of women were eligible for IAP. Indications were GBS carriage alone (21%), CRF alone (13% ) and both (5% ). Compliance was similar for GBS carriers at both hospitals: 78% at Hospital A and 76% at Hospital B. However, because of the poor predictive value of screening before 32 weeks, only 65%of intrapartum GBS carriers actually received IAP. For women with CRF only, compliance was significantly lower at Hospital B than Hospital A (56 vs. 75%; p= 0.03).

Conclusions: According to currently recommended protocols, about one-third of healthy women are eligible for intrapartum antibiotics to prevent neonatal GBS sepsis. In practice, antibiotics are often used inefficiently because of poor compliance with protocols and poor predictive values of selection criteria. Better implementation strategies should improve compliance, but GBS vaccines are needed to replace prophylactic antibiotic use, with its associated disadvantages.

Full Text

The Full Text of this article is available as a PDF (135.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyer K. M., Gadzala C. A., Kelly P. D., Gotoff S. P. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission. J Infect Dis. 1983 Nov;148(5):810–816. doi: 10.1093/infdis/148.5.810. [DOI] [PubMed] [Google Scholar]
  2. Cheon-Lee E., Amstey M. S. Compliance with the Centers for Disease Control and Prevention antenatal culture protocol for preventing group B streptococcal neonatal sepsis. Am J Obstet Gynecol. 1998 Jul;179(1):77–79. doi: 10.1016/s0002-9378(98)70253-4. [DOI] [PubMed] [Google Scholar]
  3. Connellan M., Wallace E. M. Prevention of perinatal group B streptococcal disease: screening practice in public hospitals in Victoria. Med J Aust. 2000 Apr 3;172(7):317–320. doi: 10.5694/j.1326-5377.2000.tb123977.x. [DOI] [PubMed] [Google Scholar]
  4. Garland S. M., Fliegner J. R. Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis. Aust N Z J Obstet Gynaecol. 1991 May;31(2):119–122. doi: 10.1111/j.1479-828x.1991.tb01797.x. [DOI] [PubMed] [Google Scholar]
  5. Gervasio C. T., Mantaring B. S., Alankar S., Shankaran S. Early-onset neonatal group B streptococcal sepsis: intrapartum antibiotic prophylaxis in the clinical setting. J Perinatol. 2001 Jan-Feb;21(1):9–14. doi: 10.1038/sj.jp.7200476. [DOI] [PubMed] [Google Scholar]
  6. Gibbs R. S., McDuffie R. S., Jr, McNabb F., Fryer G. E., Miyoshi T., Merenstein G. Neonatal group B streptococcal sepsis during 2 years of a universal screening program. Obstet Gynecol. 1994 Oct;84(4):496–500. [PubMed] [Google Scholar]
  7. Gilbert G. L., Hewitt M. C., Turner C. M., Leeder S. R. Epidemiology and predictive values of risk factors for neonatal group B streptococcal sepsis. Aust N Z J Obstet Gynaecol. 2002 Nov;42(5):497–503. doi: 10.1111/j.0004-8666.2002.00497.x. [DOI] [PubMed] [Google Scholar]
  8. Gilbert G. L., Isaacs D., Burgess M. A., Garland S. M., Grimwood K., Hogg G. G., McIntyre P. Prevention of neonatal group B streptococcal sepsis: is routine antenatal screening appropriate. Aust N Z J Obstet Gynaecol. 1995 May;35(2):120–126. doi: 10.1111/j.1479-828x.1995.tb01853.x. [DOI] [PubMed] [Google Scholar]
  9. Heim K., Alge A., Marth C. Anaphylactic reaction to ampicillin and severe complication in the fetus. Lancet. 1991 Apr 6;337(8745):859–860. doi: 10.1016/0140-6736(91)92574-l. [DOI] [PubMed] [Google Scholar]
  10. Idsoe O., Guthe T., Willcox R. R., de Weck A. L. Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. Bull World Health Organ. 1968;38(2):159–188. [PMC free article] [PubMed] [Google Scholar]
  11. Isaacs D. Prevention of early onset group B streptococcal infection: screen, treat, or observe? Arch Dis Child Fetal Neonatal Ed. 1998 Sep;79(2):F81–F82. doi: 10.1136/fn.79.2.f81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jeffery H. E., McIntosh E. D. Antepartum screening and non-selective intrapartum chemoprophylaxis for group B streptococcus. Aust N Z J Obstet Gynaecol. 1994 Feb;34(1):14–19. doi: 10.1111/j.1479-828x.1994.tb01031.x. [DOI] [PubMed] [Google Scholar]
  13. Jeffery H. E., Moses Lahra M. Eight-year outcome of universal screening and intrapartum antibiotics for maternal group B streptococcal carriers. Pediatrics. 1998 Jan;101(1):E2–E2. doi: 10.1542/peds.101.1.e2. [DOI] [PubMed] [Google Scholar]
  14. Levine E. M., Ghai V., Barton J. J., Strom C. M. Intrapartum antibiotic prophylaxis increases the incidence of gram-negative neonatal sepsis. Infect Dis Obstet Gynecol. 1999;7(4):210–213. doi: 10.1002/(SICI)1098-0997(1999)7:4<210::AID-IDOG10>3.0.CO;2-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lin F. Y., Brenner R. A., Johnson Y. R., Azimi P. H., Philips J. B., 3rd, Regan J. A., Clark P., Weisman L. E., Rhoads G. G., Kong F. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol. 2001 May;184(6):1204–1210. doi: 10.1067/mob.2001.113875. [DOI] [PubMed] [Google Scholar]
  16. Mercer B. M., Carr T. L., Beazley D. D., Crouse D. T., Sibai B. M. Antibiotic use in pregnancy and drug-resistant infant sepsis. Am J Obstet Gynecol. 1999 Oct;181(4):816–821. doi: 10.1016/s0002-9378(99)70307-8. [DOI] [PubMed] [Google Scholar]
  17. Mohle-Boetani J. C., Schuchat A., Plikaytis B. D., Smith J. D., Broome C. V. Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis. JAMA. 1993 Sep 22;270(12):1442–1448. [PubMed] [Google Scholar]
  18. Morales W. J., Dickey S. S., Bornick P., Lim D. V. Change in antibiotic resistance of group B streptococcus: impact on intrapartum management. Am J Obstet Gynecol. 1999 Aug;181(2):310–314. doi: 10.1016/s0002-9378(99)70553-3. [DOI] [PubMed] [Google Scholar]
  19. Peralta-Carcelen M., Fargason C. A., Jr, Cliver S. P., Cutter G. R., Gigante J., Goldenberg R. L. Impact of maternal group B streptococcal screening on pediatric management in full-term newborns. Arch Pediatr Adolesc Med. 1996 Aug;150(8):802–808. doi: 10.1001/archpedi.1996.02170330028005. [DOI] [PubMed] [Google Scholar]
  20. Rosenstein N. E., Schuchat A. Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis. The Neonatal Group B Streptococcal Disease Study Group. Obstet Gynecol. 1997 Dec;90(6):901–906. doi: 10.1016/s0029-7844(97)00486-9. [DOI] [PubMed] [Google Scholar]
  21. Sanders Toni R., Roberts Christine L., Gilbert Gwendolyn L. Compliance with a protocol for intrapartum antibiotic prophylaxis against neonatal group B streptococcal sepsis in women with clinical risk factors. Infect Dis Obstet Gynecol. 2002;10(4):223–229. doi: 10.1155/S1064744902000261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Schrag Stephanie J., Zell Elizabeth R., Lynfield Ruth, Roome Aaron, Arnold Kathryn E., Craig Allen S., Harrison Lee H., Reingold Arthur, Stefonek Karen, Smith Glenda. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med. 2002 Jul 25;347(4):233–239. doi: 10.1056/NEJMoa020205. [DOI] [PubMed] [Google Scholar]
  23. Schrag Stephanie, Gorwitz Rachel, Fultz-Butts Kristi, Schuchat Anne. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002 Aug 16;51(RR-11):1–22. [PubMed] [Google Scholar]
  24. Smaill F. Intrapartum antibiotics for group B streptococcal colonisation. Cochrane Database Syst Rev. 2000;(2):CD000115–CD000115. doi: 10.1002/14651858.CD000115. [DOI] [PubMed] [Google Scholar]
  25. Towers C. V., Carr M. H., Padilla G., Asrat T. Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol. 1998 Oct;179(4):879–883. doi: 10.1016/s0002-9378(98)70182-6. [DOI] [PubMed] [Google Scholar]
  26. Towers Craig V., Briggs Gerald G. Antepartum use of antibiotics and early-onset neonatal sepsis: the next 4 years. Am J Obstet Gynecol. 2002 Aug;187(2):495–500. doi: 10.1067/mob.2002.124277. [DOI] [PubMed] [Google Scholar]
  27. Vigneswaran R., O'Loughlin J. A., McDonald H. M. Prevention of early onset group B streptococcal sepsis in the newborn. J Paediatr Child Health. 1995 Dec;31(6):493–494. doi: 10.1111/j.1440-1754.1995.tb00869.x. [DOI] [PubMed] [Google Scholar]
  28. Voluménie J. L., Fernandez H., Vial M., Lebrun L., Frydman R. Neonatal group B streptococcal infection. Results of 33 months of universal maternal screening and antibioprophylaxis. Eur J Obstet Gynecol Reprod Biol. 2001 Jan;94(1):79–85. doi: 10.1016/s0301-2115(00)00340-7. [DOI] [PubMed] [Google Scholar]
  29. Yancey M. K., Schuchat A., Brown L. K., Ventura V. L., Markenson G. R. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol. 1996 Nov;88(5):811–815. doi: 10.1016/0029-7844(96)00320-1. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES